| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16729-352-10 | 16729-352 | HUMAN PRESCRIPTION DRUG | Vilazodone Hydrochloride | Vilazodone Hydrochloride | TABLET | ORAL | 20220604 | N/A | ANDA | ANDA208209 | Accord Healthcare Inc. | VILAZODONE HYDROCHLORIDE | 10 mg/1 | 30 TABLET in 1 BOTTLE (16729-352-10) |
| 72603-127-01 | 72603-127 | HUMAN PRESCRIPTION DRUG | Vilazodone Hydrochloride | Vilazodone Hydrochloride | TABLET | ORAL | 20230201 | 20250331 | ANDA | ANDA208209 | NorthStar RxLLC | VILAZODONE HYDROCHLORIDE | 40 mg/1 | 30 TABLET in 1 BOTTLE (72603-127-01) |
| 16729-353-10 | 16729-353 | HUMAN PRESCRIPTION DRUG | Vilazodone Hydrochloride | Vilazodone Hydrochloride | TABLET | ORAL | 20220604 | N/A | ANDA | ANDA208209 | Accord Healthcare Inc. | VILAZODONE HYDROCHLORIDE | 20 mg/1 | 30 TABLET in 1 BOTTLE (16729-353-10) |
| 16729-354-10 | 16729-354 | HUMAN PRESCRIPTION DRUG | Vilazodone Hydrochloride | Vilazodone Hydrochloride | TABLET | ORAL | 20220604 | N/A | ANDA | ANDA208209 | Accord Healthcare Inc. | VILAZODONE HYDROCHLORIDE | 40 mg/1 | 30 TABLET in 1 BOTTLE (16729-354-10) |